These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12502879)

  • 21. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
    You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
    Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.
    Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P
    J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
    Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
    Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering better vaccines for foot-and-mouth disease.
    Mason PW; Chinsangaram J; Moraes MP; Mayr GA; Grubman MJ
    Dev Biol (Basel); 2003; 114():79-88. PubMed ID: 14677679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs.
    Cao Y; Lu Z; Li Y; Sun P; Li D; Li P; Bai X; Fu Y; Bao H; Zhou C; Xie B; Chen Y; Liu Z
    Antiviral Res; 2013 Feb; 97(2):145-53. PubMed ID: 23219974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.
    de Avila Botton S; Brum MC; Bautista E; Koster M; Weiblen R; Golde WT; Grubman MJ
    Vaccine; 2006 Apr; 24(17):3446-56. PubMed ID: 16522345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine.
    Pacheco JM; Brum MC; Moraes MP; Golde WT; Grubman MJ
    Virology; 2005 Jul; 337(2):205-9. PubMed ID: 15893355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine.
    Alejo DM; Moraes MP; Liao X; Dias CC; Tulman ER; Diaz-San Segundo F; Rood D; Grubman MJ; Silbart LK
    Vaccine; 2013 Apr; 31(18):2302-9. PubMed ID: 23499593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel antiviral therapeutics to control foot-and-mouth disease.
    Dias CC; Moraes MP; Weiss M; Diaz-San Segundo F; Perez-Martin E; Salazar AM; de los Santos T; Grubman MJ
    J Interferon Cytokine Res; 2012 Oct; 32(10):462-73. PubMed ID: 22924938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of Adt-O1Manisa and Ad5-boIFNλ3 induces early protective immunity against foot-and-mouth disease in cattle.
    Diaz-San Segundo F; Montiel NA; Sturza DF; Perez-Martin E; Hickman D; Ramirez-Medina E; Grubman MJ; de Los Santos T
    Virology; 2016 Dec; 499():340-349. PubMed ID: 27743960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine.
    Diaz-San Segundo F; Dias CC; Moraes MP; Weiss M; Perez-Martin E; Salazar AM; Grubman MJ; de Los Santos T
    Virology; 2014 Nov; 468-470():283-292. PubMed ID: 25216089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus-mediated expression of interferon-alpha delays viral replication and reduces disease signs in swine challenged with porcine reproductive and respiratory syndrome virus.
    Brockmeier SL; Lager KM; Grubman MJ; Brough DE; Ettyreddy D; Sacco RE; Gauger PC; Loving CL; Vorwald AC; Kehrli ME; Lehmkuhl HD
    Viral Immunol; 2009 Jun; 22(3):173-80. PubMed ID: 19435413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
    Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X
    Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early detection and visualization of human adenovirus serotype 5-viral vectors carrying foot-and-mouth disease virus or luciferase transgenes in cell lines and bovine tissues.
    Montiel N; Smoliga G; Arzt J
    Vaccine; 2012 Feb; 30(9):1690-701. PubMed ID: 22227230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.